Literature DB >> 15257187

Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.

Nicola de Luca1, Roland G Asmar, Gérard M London, Michael F O'Rourke, Michel E Safar.   

Abstract

OBJECTIVE: In hypertension, blockade of the renin-angiotensin system reduces left ventricular mass (LVM) independently of brachial systolic (S), diastolic (D), and mean (M) blood pressure (BP). From central to peripheral arteries, MBP and DBP are practically unchanged, whereas SBP and pulse pressure (PP) increase significantly. The objective was to determine whether changes in LVM under drug treatment was preferentially associated with changes in central or brachial SBP and PP.
DESIGN: A substudy of 146 subjects was selected from 469 hypertensive patients submitted to a double-blind randomized trial comparing the combination of perindopril (2 mg; Per) and indapamide (0.625 mg; Ind) with atenolol (50 mg, one tablet per day). MAIN OUTCOME MEASURES: Before and after 1 year of treatment: LVM (echocardiography) in 146 subjects and, in 52 of them, central (carotid) BP and timing of wave reflections (tonometry).
RESULTS: LVM changes were significantly associated with antihypertensive treatment, with lower LVM with Per/Ind than with atenolol. Changes in SBP and PP, but not in MBP and DBP, were more significantly associated with Per/Ind than with atenolol, with more pronounced effects using central than brachial measurements, and a longer delay in central return of wave reflections under Per/Ind. In the sampling of 52 patients with tonometry, the change in LVM between the two drug regimens was significantly linked to central, but not brachial, PP change.
CONCLUSIONS: This observational study shows a lower LVM under Per/Ind than under atenolol. The greater change in LVM on Per/Ind was linked to central and not brachial blood pressure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257187     DOI: 10.1097/01.hjh.0000125448.28861.fc

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  41 in total

1.  Association of left ventricular diastolic dysfunction with 24-h aortic ambulatory blood pressure: the SAFAR study.

Authors:  Y Zhang; G Kollias; A A Argyris; T G Papaioannou; C Tountas; G D Konstantonis; A Achimastos; J Blacher; M E Safar; P P Sfikakis; A D Protogerou
Journal:  J Hum Hypertens       Date:  2014-11-13       Impact factor: 3.012

Review 2.  Noninvasive studies of central aortic pressure.

Authors:  Michael F O'Rourke; Audrey Adji
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 3.  Arterial aging: a review of the pathophysiology and potential for pharmacological intervention.

Authors:  Michael F O'Rourke; Audrey Adji; Mayooran Namasivayam; Jonathan Mok
Journal:  Drugs Aging       Date:  2011-10-01       Impact factor: 3.923

Review 4.  Arterial aging--hemodynamic changes and therapeutic options.

Authors:  Michel E Safar
Journal:  Nat Rev Cardiol       Date:  2010-08       Impact factor: 32.419

Review 5.  Can antihypertensive treatment reverse large-artery stiffening?

Authors:  Michel E Safar
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

Review 6.  Impact of Antihypertensive Agents on Central Systolic Blood Pressure and Augmentation Index: A Meta-Analysis.

Authors:  Tracey J McGaughey; Emily A Fletcher; Sachin A Shah
Journal:  Am J Hypertens       Date:  2015-08-19       Impact factor: 2.689

Review 7.  Arterial stiffness: is it ready for prime time?

Authors:  Stanley S Franklin
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

8.  Association of left ventricular structural and functional abnormalities with aortic and brachial blood pressure variability in hypertensive patients: the SAFAR study.

Authors:  C Chi; S-K Yu; R Auckle; A A Argyris; E Nasothimiou; C Tountas; E Aissopou; J Blacher; M E Safar; P P Sfikakis; Y Zhang; A D Protogerou
Journal:  J Hum Hypertens       Date:  2017-06-01       Impact factor: 3.012

Review 9.  Central blood pressure, arterial stiffness, and wave reflection: new targets of treatment in essential hypertension.

Authors:  Lorenzo Ghiadoni; Rosa Maria Bruno; Francesco Stea; Agostino Virdis; Stefano Taddei
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 10.  Arterial stiffness, hypertension, and rational use of nebivolol.

Authors:  Enrico Agabiti-Rosei; Enzo Porteri; Damiano Rizzoni
Journal:  Vasc Health Risk Manag       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.